Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
3.19M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
193K
-
Shares change
-
-4.9K
-
Total reported value, excl. options
-
$385K
-
Value change
-
-$102K
-
Number of buys
-
5
-
Number of sells
-
-5
-
Price
-
$2.00
Significant Holders of AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value (ATXI) as of Q4 2024
11 filings reported holding ATXI - AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value as of Q4 2024.
AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value (ATXI) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 193K shares
of 3.19M outstanding shares and own 6.04% of the company stock.
Largest 10 shareholders include Ikarian Capital, LLC (140K shares), BOOTHBAY FUND MANAGEMENT, LLC (41.1K shares), UBS Group AG (7.92K shares), Tower Research Capital LLC (TRC) (3.1K shares), WELLS FARGO & COMPANY/MN (500 shares), BANK OF AMERICA CORP /DE/ (14 shares), SBI Securities Co., Ltd. (9 shares), SABBY MANAGEMENT, LLC (0 shares), JPMORGAN CHASE & CO (0 shares), and Moss Adams Wealth Advisors LLC (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.